Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. Founded by Andrew Delong, Brendan Frey, and Hui Yuan Xiong in 2014, Deep Genomics is backed by Creative Destruction Lab (CDL), Fidelity Management and Research Company, True Ventures, SoftBank Vision Fund, and Khosla Ventures and is headquartered in Toronto.